Content in this section will include AAPM advocacy efforts, legislative news, public statements, etc.

Trump Administration Announces $1.8 Billion in Funding to States to Continue Combating Opioid Crisis

The U.S. Department of Health and Human Services (HHS) announced more than $1.8 billion in funding to states to continue the Trump administration's efforts to combat the opioid crisis by expanding access to treatment and supporting near real-time data on the drug overdose crisis.

Continue reading
Topics:

6 Key Steps that States Should Take Now to End the Opioid Epidemic

The AMA has released a national policy road map based on in-depth analysis of the response to the opioid epidemic by four states: Colorado, Mississippi, North Carolina and Pennsylvania. The report , " National Roadmap on...
Continue reading
Topics:

WHO Revision of Pain Management Guidelines: A Call for Experts

The World Health Organization (WHO) announces the revision process for two recently discontinued documents: "Ensuring balance in national policies on controlled substances: Guidance for availability and accessibility of controlled medicines" (2011) and "WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses" (2012). A Call for Experts was issued as part of identifying potential members of the guideline development groups.

Continue reading
Topics:

Can I Call Myself a “Pain Specialist?”

  Who defines the role of pain specialists? Do you qualify as one, and do the courts agree? Inside the legal requirements. Full story.  
Topics:

Request for Information: Guidance on Current Education Curricula for Health Care Professionals Regarding Pain and Opioid Misuse and Use Disorder

NIH has issued a Request for Information to gather input from the scientific research and medical education communities and the general public regarding the Centers for Excellence in Pain Education (CoEPEs) program, gene...
Continue reading
Topics:
NIH

FDA Approves First Generics of Lyrica

The U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of ...
Continue reading

Report from the June 2019 AMA Annual Meeting

The following report was submitted by Robert Wailes, MD, AAPM AMA Delegate The Annual Meeting of the American Medical Association (AMA) House of Delegates (HOD) convened from June 8-12, in Chicago, Illinois. I repre...
Continue reading
Topics:
AMA

AMA House of Delegates Annual Meeting Update

Pain medicine was represented at the recent American Medical Association House of Delegates (HOD) Annual Meeting by AAPM delegate Robert Wailes, MD , and alternate delegate Donna Bloodworth, MD . Among topics discussed, ...
Continue reading
Topics:
AMA

FDA MedWatch Safety Alert: RXQ Compounding, LLC Issues Voluntary Nationwide Recall of All Sterile Products

 RXQ Compounding, LLC ("RXQ") is voluntarily recalling all sterile human and animal products within expiry to the user level due to lack of sterility process assurance associated with the production of the Company's...
Continue reading
Topics:
FDA

AMA Opioid Task Force Recommendations Offer Roadmap to Policymakers

The recommendations include tangible actions policymakers can take to help reduce barriers to evidence-based treatment and end the nation's opioid epidemic. AAPM is among the 25 specialty and state medical societies that...
Continue reading
Topics:
AMA

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More